
|Articles|September 19, 2022
SynForU™- HerCare: Empowering "HER" With Clinically Validated Probiotics
Author(s)Synbio
Vulvovaginal Candidiasis (VVC) affects 75% of reproductive-age women, it is especially common during pregnancy due to higher estrogen levels and glycogen content in vaginal secretions. The latest clinical study conducted in pregnant subjects showed that SynForU™-HerCare, Lactobacilli probiotics reduce vulvovaginal symptoms, decrease emotional stress, reduce impairment of daily activities attributed to the infection, and improve defecation times. Download the whitepaper to find out how clinically validated probiotics can promote women's wellness inside-out.
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
New Report Calls for Combined Sodium-Potassium Strategy in Hypertension Management
2
Ross Introduces 250-Gallon Retention Mixers for High-Pressure Processing
3
The Council for Responsible Nutrition Responds to NYT's AI Wellness Influencer Investigation
4
Study Finds Popular AI Calorie-Tracking Apps Underestimate Meal Energy by About a Third
5
